The US Food and Drug Administration (FDA) has approved a second blood test to detect Alzheimer’s disease, potentially speeding diagnosis for millions of patients. The Elecsys...
Nimacimab significantly enhanced weight loss when combined with GLP-1 therapy without adding side effects, according to mid-stage clinical trial results involving 136 adults. The experimental drug...
Ultra-fast MRI scans taking under seven minutes could double NHS dementia testing capacity and help boost diagnosis rates across the UK, experts have said. Scientists have...
Weight loss jabs such as Mounjaro and Wegovy could make some cancer scans less effective, leading to unnecessary tests and possible delays in treatment, experts suggest....
Scientists have developed an innovative technique to observe Alzheimer’s disease as it progresses in the brain – a breakthrough that could accelerate the development of new...
NeuroClin – formerly known as Glasgow Memory Clinic – has partnered with Advance Tests to launch Scotland’s first commercially available blood biomarker test for early Alzheimer’s...
Ageing alters the brain’s shape in measurable ways that could provide early warning signs of dementia, potentially years before symptoms appear, researchers say. Analysis of more...
